We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Image: A new study identified 17 plasma proteins linked to mortality in older adults, several of which also track biological ageing across multiple organ systems. (Image Credit: Adobe Stock)

Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems

New data identify mortality-linked plasma proteins that track biological age across organs, refining prognostic markers. More...
28 Oct 2026
Image: The OSOM COVID-19/Flu A&B Combo Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen. (Photo courtesy of Sekisui Diagnostics)

COVID-19 and Flu Combo Test Launches With FDA Clearance

Sekisui Diagnostics has launched the 510(k)-cleared OSOM COVID-19/Flu A&B Combo Test for use in professional healthcare settings. More...
28 Oct 2026
Image: Distinct tau isoform signatures in Alzheimer\'s disease and amyotrophic lateral sclerosis. (Abu-Rumeileh, S., Großkopf, H., Guthknecht, A. et al. Nature Communications, 2026. DOI: 10.1038/s41467-026-78390-3)

Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis

A new two-step blood test isolates brain-derived tau, boosting p-tau217 specificity for Alzheimer’s and reducing false positives. More...
28 Oct 2026
Image: Roche’s CE-marked cobas smart e immunoanalyser brings Elecsys immunoassay testing to smaller and decentralized laboratories in a compact benchtop platform. (Photo courtesy of Roche)

Compact Immunoanalyzer Gains CE Mark for Testing Across Local Care Settings

Roche has received the CE Mark for its compact cobas smart e immunoanalyser, designed for central-lab performance in under one square meter. More...
28 Oct 2026
Image: The updated framework is intended for use in molecular diagnostic reports, tumor board discussions, clinical guidelines, and routine treatment planning (Image Credit: Shutterstock)

Updated Framework Guides Assessment of Actionable Cancer Biomarkers

ESMO has updated its ESCAT framework to help oncologists assess molecular alterations and match patients with targeted therapies. More...
27 Oct 2026
Image Credit: Adobe Stock

Genomic Tissue Test Predicts Metastasis and Abiraterone Benefit in High-Risk Prostate Cancer

A tissue-based molecular test stratifies prostate cancer spread risk and identifies patients who may benefit from therapy.

More...
27 Oct 2026
Photo courtesy of Tempus AI

RNA Sequencing Assay Gains EU Certification for Solid Tumor Profiling

The Tempus xR assay has received certification under the EU’s IVDR as a Class C in vitro diagnostic device. More...
27 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Copyright © 2000-2026 Globetech Media. All rights reserved.